The market is weaker today and it is bringing down the sector, although it appears that biotechs are underperforming the broader market. It does not appear that this underperformance is.
A relatively good start to the week with only one slight worry. While the sector is generally green with the market, large cap biotechs are noticeably weaker. While it might.
I am back but have not really followed the market the past couple of days. My sense is that it has been relatively weak and could be setting up for.
I am back after a small break and I hope that nobody missed me. The market certainly did not miss me as not much has really happened on the news.
Another slow day in the market in terms of news, so I want to round out a couple of ideas today. Nothing has really changed in relation to my views.
A good start to the week with the markets a little week but the sector outperforming. This is not totally surprising given the underperformance last week in that there should.
So it looks like the sector wants to go lower. While there can be any number of explanations the proximate cause is the GILD report, so I want to go.
I want to write this quick to get it out as I spent the morning taking the children to the dentist, so I have a late start. The market is.
A bad start for the market in terms of earnings, economic data, and price action. It appears that FX and the capital spending decline coming from oil prices is creating.
It has been sort of a mixed bag with the sector despite some decent macro tailwinds with the European QE program. I am not saying the sector has been bad.